A drug development company with an innovative model for Clinical Development.
We offer a compelling opportunity to partner late phase therapeutic projects for approval in the EU and US and to accelerate their availability to market.
We offer a compelling opportunity to partner late phase therapeutic projects for approval in the EU and US and to accelerate their availability to market.
Location: United Kingdom, England, London
Employees: 11-50
Founded date: 2013
Investors 1
| Date | Name | Website |
| - | Abingworth... | abingworth... |
Mentions in press and media 1
| Date | Title | Description |
| 28.01.2013 | Avillion Receives Funding from Abingworth and Clarus Ventures | Avillion LLP, a London, UK-based company that focuses on clinical co-development of therapeutics, received initial funding from Abingworth LLP and Clarus Ventures. Led by Lewis Cameron, CEO, John Bradshaw, CFO, and Dr Allison Jeynes-Ellis, ... |